NCT05358418 (START) is a clinical trial of AIS,START with films transferring in Trauma, sponsored by Chia-hsi Chen.

Who is sponsoring NCT05358418?

NCT05358418 is sponsored by Chia-hsi Chen.

What drugs are being tested in NCT05358418?

Interventions in NCT05358418: AIS,START with films transferring.

What condition does NCT05358418 study?

NCT05358418 studies Trauma, Disaster.

Is NCT05358418 still recruiting?

NCT05358418 is currently completed. Last updated 24 November 2023.

Last reviewed 2023-11-24 · How we verify

NCT05358418: START

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

AIS and START Grade With Films Transferring in Disaster Management

Completed Last updated 24 November 2023

What this trial tests

trial testing AIS,START with films transferring in Trauma in 90 participants. Completed in 30 September 2023.

Timeline

1 December 2022

Primary endpoint
10 June 2023

30 September 2023

Quick facts

Lead sponsor	Chia-hsi Chen
Status	Completed
Study type	OBSERVATIONAL
Enrollment	90
Start date	1 December 2022
Primary completion	10 June 2023
Estimated completion	30 September 2023
Sites	1 location across Taiwan

Drugs / interventions tested

AIS,START with films transferring

Conditions studied

Trauma — all drugs for Trauma →
Disaster — all drugs for Disaster →

Sponsor

Chia-hsi Chen

Who can join

Eligibility, any sex, with Trauma or Disaster. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Disaster medical teams are formed by hospitals in response to the manpower needs of a large number of injured and sick patients. The current planning of hospitals for a large number of disaster medical manpower is too superficial. The application of today's inspection methods in the treatment of a large number of injured patients is not as good as it is. Therefore, understanding the scene situation has become the key point of manpower deployment. Today's internet transmission speed and computer artificial intelligence technology are very different from 9 years ago. The investigators adopt one more simple and easy-to-operate inspection method and use artificial intelligence technology to assist.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Trauma

Currently open trials in the same condition.

NCT07290634 — Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion · recruiting
NCT07485231 — Nitric Oxide (NO) and Endothelial Dysfunction in Women With PTSD · NA · recruiting
NCT07473336 — The Effectiveness of RAPID-Based Psychological First Aid Training · NA · active not recruiting
NCT07278505 — Study of Cannabidiol and Neuroimaging on Stress · Phase 1, PHASE2 · recruiting
NCT02880163 — REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05358418 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chia-hsi Chen
Last refreshed: 24 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05358418.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing